isophosphamide mustard has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaput, N; Delahousse, J; Desbois, M; Paci, A; Perfettini, JL; Skarbek, C | 1 |
| Bertram, B; Hilgard, P; Nowrousian, MR; Pohl, J; Stüben, J; Wiessler, M | 1 |
2 other study(ies) available for isophosphamide mustard and Disease Models, Animal
| Article | Year |
|---|---|
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Disease Models, Animal; Female; Humans; Immune Checkpoint Inhibitors; Mice; Phosphoramide Mustards | 2020 |
D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport.
Topics: Absorption; Administration, Oral; Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Disease Models, Animal; Drug Evaluation; Drug Tolerance; Female; Glucose; Ifosfamide; Kidney; Leukocytes; Mice; Monosaccharide Transport Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Phlorhizin; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Spleen; Tumor Cells, Cultured | 1995 |